Testis cancer patients fare poorly under ACA March 22, 2017By Lisette HiltonSince passage of the Affordable Care Act, the number of testicular cancer patients with insurance has dwindled, while rates of advanced testis cancer have climbed, according to a recent study. Bladder Ca linked to risk of second primary cancerAmong survivors of the most common types of cancer, bladder cancer survivors have the highest risk for developing a second primary cancer, according to a recent study. Urologist work force retirement study sounds alarm June 29, 2016By Lisette HiltonMore than one-fourth of the U.S. urologist work force plans to retire in next 5 years, according to a new study looking at the near-term impact of retirement on the specialty. Data weigh neuromodulation’s impact on QoL at 3 years May 09, 2016By Randy DotingaEvaluation of the InterStim system in patients with urgency incontinence, urgency frequency, or both suggests benefits beyond urinary symptom relief. How number of Peyronie’s Tx cycles affects outcomesIn a study of intralesional collagenase clostridium histolyticum, mean curvature was reduced most dramatically after the first cycle, researchers reported. Urinary proteome may hold key to stone preventionA recent study provides the first comprehensive catalog of urinary calcium oxalate monohydrate binding proteins. Enucleation for RCC yields multiple benefitsThe procedure maximally preserves normal renal parenchyma and provides better surgical precision than standard partial nephrectomy, researchers report. VUR: What goes into parents’ treatment choicesResearchers looking to create a shared decision-making tool identify 13 major themes when interviewing parents of children with VUR. Prostate biopsy-related infections raise transfusion risk May 08, 2016By Mac OvermyerParadoxically, the authors of a large study did not find a negative effect in functional outcomes analyzed. Data offer new insight on HIFU’s use in low-risk PCa May 07, 2016By Randy DotingaTransrectal HIFU shows a statistically significant increase in per-core negative biopsy rates.